Many patients undergoing lumpectomy surgery at JFK Medical Center for the removal of breast cancer are benefitting from new intra-operative technology that detects microscopic amounts of cancer cells within 1 mm of the edges of removed tissue, which are otherwise not visible during the surgery.
JFK Medical Center is the first in Florida to utilize MarginProbe(r) for early stage breast cancer. Manufactured and marketed by Dune Medical Devices, MarginProbe utilizes non-destructive radio-frequency spectroscopy technology in the operating room to analyze the outer margins of removed tissue to detect traces of cancer cells. If cancer cells are detected along the margins of the removed tissue, the surgeon excises additional tissue from the surgical site to ensure that no additional cancer cells remain.
